DDrare: Database of Drug Development for Rare Diseases

Nebulized combination ipratropium bromide with salbutamol (DrugBank: Ipratropium, Salbutamol)

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02782052 (ClinicalTrials.gov)	July 2016	17/5/2016	Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension	Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension	Pulmonary Arterial Hypertension	Drug: Nebulized ipratropium bromide;Drug: Nebulized combination ipratropium bromide with salbutamol;Drug: Nebulized Placebo	Assistance Publique - Hôpitaux de Paris	NULL	Withdrawn	18 Years	N/A	All	0	Phase 3	NULL

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

July 2016

17/5/2016

Bronchodilator's Effects on Exertional Dyspnoea in Pulmonary Arterial Hypertension

Pulmonary Arterial Hypertension

Drug: Nebulized ipratropium bromide;Drug: Nebulized combination ipratropium bromide with salbutamol;Drug: Nebulized Placebo

Assistance Publique - Hôpitaux de Paris

NULL

Withdrawn

18 Years

N/A

All

Phase 3

NULL